MONTREAL, Sept. 11, 2018 /CNW/ - DMD Digital Health Connections Group Inc. ("DMD")(NEX: DMG.H) is pleased to announce that two leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and Glass Lewis & Co. ("Glass Lewis"), have each recommended that shareholders vote in favour of the proposed plan of arrangement (the "Arrangement") involving DMD and 10653365 Canada Inc.
These are important endorsements from independent third parties whose recommendations are intended to assist shareholders in making proxy voting decisions. Both ISS and Glass Lewis have conducted a careful review of the Company's disclosure materials before making their recommendations.
Both ISS and Glass Lewis are independent proxy advisory firms who, among other services, provide proxy voting recommendations to pension funds, investment managers, mutual funds and other institutional shareholders.
ISS and Glass Lewis have recommended that shareholders of DMD vote FOR the Arrangement Resolution. ISS noted "In light of the significant premium, the favourable market reaction, and reasonable strategic rationale, shareholder approval of this resolution is warranted." Glass Lewis noted "we believe the proposed transaction is reasonable and in the best interests of shareholders"
We remind shareholders that the cut-off for voting is 5:00 PM (Montreal time) on September 14, 2018
YOUR VOTE IS IMPORTANT - PLEASE VOTE TODAY
How to Vote
Vote using the following methods prior to the meeting
Registered Holders- Shares held in own name and represented by a physical certificate
- By Internet: www.investorvote.com
- By Telephone: 1-866-732-8683
Beneficial Holders - Shares held with a broker, bank or other intermediary
- By Internet: www.proxyvote.com
- By Telephone: Call number(s) listed on your voting instruction forms
The annual and special meeting of DMD shareholders is scheduled to be held at 8:00 a.m. (Montreal time) on Wednesday, September 14, 2018 at Estrimont, 44 avenue de L'Auberge, Oxford, Quebec.
Additional information concerning the Arrangement can be found in the management information circular dated August 27, 2018 (the "Circular"). An electronic copy of the Circular is available on SEDAR under the issuer profile at www.sedar.com.
Shareholder Information and Questions
DMD shareholders who need assistance with voting their shares or making the appropriate election on the Letter of Transmittal can contact our proxy solicitation agent, Laurel Hill Advisory Group:
Laurel Hill Advisory Group
North America Toll Free: 1-877-452-7184
Collect Calls Outside North America: 1-416-304-0211
Email: [email protected]
Shareholders are encouraged to vote today using the internet, telephone or facsimile.
About DMD Digital Health Connections Group Inc. ("DMD")
DMD enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Several pharmaceutical companies, agencies and healthcare organizations have adopted DMD's solutions to target, engage and interact with healthcare practitioners. For more information, visit www.dmdconnects.com.
Neither NEX platform of the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE DMD Digital Health Connections Group Inc.
For further information: Laurel Hill Advisory Group, North America Toll Free: 1-877-452-7184, Collect Calls Outside North America: 1-416-304-0211, Email: [email protected]